russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-2098Research ArticleПЕРЕДОВАЯ СТАТЬЯЛЕКАРСТВЕННАЯ ТЕРАПИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ: ДАННЫЕ ДОКАЗАТЕЛЬНОЙ МЕДИЦИНЫ И РЕАЛЬНАЯ КЛИНИЧЕСКАЯ ПРАКТИКАDRUG THERAPY OF CARDIOVASCULAR DISEASES: DATA OF EVIDENCE-BASED MEDICINE AND CLINICAL PRACTICEОгановР. Г.OganovR. G.МарцевичС. Ю.MartsevichS. Y.20012808200104811Copyright © Оганов Р.Г., Марцевич С.Ю., 20012001Оганов Р.Г., Марцевич С.Ю.Oganov R.G., Martsevich S.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/2098

Лекарственная терапия сердечно-сосудистых заболеваний: данные доказательной медицины и реальная клиническая практика.

Drug therapy of cardiovascular diseases: data of evidence-based medicine and clinical practice.

ReferencesBlumenthal R.S. Conn G. Schulman S.P. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature. J. Amer. Coll. Cardiol. 2000: 36:068-673.Blumenthal R.S. Conn G. Schulman S.P. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature. J. Amer. Coll. Cardiol. 2000: 36:068-673.Марцевич С. Ю. Проблема неэффективности длительной терапии антиангинальными препаратами больных ИБС. Кардиология 1996: 3: 27-34.Марцевич С. Ю. Проблема неэффективности длительной терапии антиангинальными препаратами больных ИБС. Кардиология 1996: 3: 27-34.Viskin S. Kitzis 1.. Lev Е. et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J. Amer. Coll. Cardiol. 1995:25: 1327-1332.Viskin S. Kitzis 1.. Lev Е. et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J. Amer. Coll. Cardiol. 1995:25: 1327-1332.Willenheimer R. Dahlof В., Gordon A. Clinical trials in cardiovascular medicine: are we looking for statistical significance or clinical relevance. Heart 2000:84: 129-133.Willenheimer R. Dahlof В., Gordon A. Clinical trials in cardiovascular medicine: are we looking for statistical significance or clinical relevance. Heart 2000:84: 129-133.Kubler W. Treatment of cardiac diseases: evidence based or 'experienced based medicine? Heart 2000; 84: 134-136.Kubler W. Treatment of cardiac diseases: evidence based or 'experienced based medicine? Heart 2000; 84: 134-136.Stelfox H.T. Chua G., O'Rourke K. Detsky A. Conflict of interest in the debate over calcium-channel antagonists. N. Engl. J. Med. 1998; 338: 101 -106.Stelfox H.T. Chua G., O'Rourke K. Detsky A. Conflict of interest in the debate over calcium-channel antagonists. N. Engl. J. Med. 1998; 338: 101 -106.Blood Pressure Lowering Treaunent Trialists' Collaboration. Etl'ects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000: 356: 1955-1964.Blood Pressure Lowering Treaunent Trialists' Collaboration. Etl'ects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000: 356: 1955-1964.Pahor M. Psaty B.M., Alderman M.H. et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000; 356: 1949-1954.Pahor M. Psaty B.M., Alderman M.H. et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000; 356: 1949-1954.HerlitzJ. Dellborg M. (Carlson B.W.etal. Long-term mortality after myocardial infarction in relation to the prescribed dosages of a beta-blocker at hospital discharge. Cardiovasc. Drugs Ther. 2001: 14:589-595.HerlitzJ. Dellborg M. (Carlson B.W.etal. Long-term mortality after myocardial infarction in relation to the prescribed dosages of a beta-blocker at hospital discharge. Cardiovasc. Drugs Ther. 2001: 14:589-595.Бухбудова Д.А. Кокурцна E.B. Бочкарева E.B. Урумбаев Р.К. Диспансеризация больных ишемической болезнью сердца. Советская медицина 1986; 1: 57-62.Бухбудова Д.А. Кокурцна E.B. Бочкарева E.B. Урумбаев Р.К. Диспансеризация больных ишемической болезнью сердца. Советская медицина 1986; 1: 57-62.Шальнова С.А. Факторы риска сердечно-сосудистых заболеваний и показатели ожидаемой продолжительности жизни населения России. Автореф. дне. док. мед. наук. М. 1999,46 с.Шальнова С.А. Факторы риска сердечно-сосудистых заболеваний и показатели ожидаемой продолжительности жизни населения России. Автореф. дне. док. мед. наук. М. 1999,46 с.Hansson L. Lindholm L. Н. Ekbom Т. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Petients with Hypertension-2 study. Lancet 1999; 354:1751-1756.Hansson L. Lindholm L. Н. Ekbom Т. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Petients with Hypertension-2 study. Lancet 1999; 354:1751-1756.ACC/AH A/ACP-ACIM Guidelines for the management of patients with chronic stable angina. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Amer. Coll. Cardiol. 1999; 33:2092-2198.ACC/AH A/ACP-ACIM Guidelines for the management of patients with chronic stable angina. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Amer. Coll. Cardiol. 1999; 33:2092-2198.de Bono D. Investigation and management of stable angina: revised guidelines 1998. Heart 1999; 81: 546-555.de Bono D. Investigation and management of stable angina: revised guidelines 1998. Heart 1999; 81: 546-555.

The authors declare that there are no conflicts of interest present.